Literature DB >> 12790766

Inhibin B, follicle stimulating hormone, luteinizing hormone, and estradiol and their relationship to the regulation of follicle development in girls during childhood and puberty.

M Chada1, R Průsa, J Bronský, M Pechová, K Kotaska, L Lisá.   

Abstract

Inhibin B, produced by granulosa cells in the ovary, is a heterodimeric glycoprotein suppressing synthesis and secretion of the follicle stimulating hormone (FSH). The aim of the present study was to determine hormone profiles of inhibin B, FSH, luteinizing hormone (LH), and estradiol in girls during childhood and puberty and to evaluate whether inhibin B is a marker of follicle development. We examined the correlation between inhibin B and gonadotropins and estradiol during the first two years and across the pubertal development. Using a specific two-side enzyme-linked immunosorbent assay (ELISA), inhibin B levels were measured in the serum of 53 healthy girls divided into 8 groups according to age. In addition, serum FSH, LH, and estradiol were measured by chemiluminescent immunoassay in all serum samples. A rise in serum levels of inhibin B (55.2+/-7.3 ng/l, mean +/- S.E.M.) and FSH (1.78+/-0.26 UI/l), concomitant with a moderate increment of serum LH (0.36+/-0.09 UI/l) and estradiol (45.8+/-12.2 pmol/l) concentrations was observed during the first three months of life and declined to prepubertal concentrations thereafter. A strong positive correlation between inhibin B and FSH (r = 0.48, p<0.05), LH (r = 0.68, p<0.001) and estradiol (r = 0.59, p<0.01) was demonstrated during the first 2 years of life. A rise in serum levels of inhibin B, FSH, LH, and estradiol was found throughout puberty. Inhibin B had a strong positive correlation with FSH (stage I of puberty: r = 0.64, p<0.05; stage II of puberty: r = 0.86, p<0.01), LH (I: r = 0.61, p<0.05; II: r = 0.67, p<0.05), and estradiol (II: r = 0.62, p<0.05) in early puberty. From pubertal stage II, inhibin B lost this relationship to gonadotropins and estradiol. Serum inhibin B and FSH levels increased significantly during pubertal development, with the highest peak found in stage III of puberty (133.5+/-14.3 ng/l), and decreased thereafter. In conclusion, inhibin B is produced in a specific pattern in response to gonadotropin stimulation and plays an important role in the regulation of the hypothalamic-pituitary-gonadal axis during childhood and puberty in girls. Inhibin B is involved in regulatory functions in developing follicles and seems to be a sensitive marker of ovarian follicle development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12790766

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  5 in total

1.  Inhibin B and luteinizing hormone levels in girls aged 6-11 years from NHANES III, 1988-1994.

Authors:  Emily K Sims; O Y Addo; Audra L Gollenberg; John H Himes; Mary L Hediger; Peter A Lee
Journal:  Clin Endocrinol (Oxf)       Date:  2012-10       Impact factor: 3.478

2.  In utero exposure to cigarette smoking, environmental tobacco smoke and reproductive hormones in US girls approaching puberty.

Authors:  Audra L Gollenberg; O Yaw Addo; Zhiwei Zhang; Mary L Hediger; John H Himes; Peter A Lee
Journal:  Horm Res Paediatr       Date:  2015-01-24       Impact factor: 2.852

3.  Primary Human Testicular Cells Self-Organize into Organoids with Testicular Properties.

Authors:  Yoni Baert; Joery De Kock; João P Alves-Lopes; Olle Söder; Jan-Bernd Stukenborg; Ellen Goossens
Journal:  Stem Cell Reports       Date:  2016-12-22       Impact factor: 7.765

4.  Herbal medicine (Jogyeongseongjang decoction) for precocious puberty girls: a retrospective study.

Authors:  Soo Bo Shim; Kyu Hee Choi; Seung Yong Lee; Jae Jun Lee; Min Seok Bu; Ju Ah Lee; In Chul Jung; Yang Chun Park; Seung Chan Park; Hye Lim Lee
Journal:  Integr Med Res       Date:  2020-02-13

Review 5.  The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesis.

Authors:  Megan M Emori; Ronny Drapkin
Journal:  Reprod Biol Endocrinol       Date:  2014-07-06       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.